지노믹트리
9,620KRWMarket close of 10/20 (Tue)
Up +0.21%+20KRWMarket close of 10/20 (Tue)
- Open
- 9,610
- High
- 9,910
- Low
- 9,230
- Day range
- Day range low 9,230 high 9,910, open 9,610, close 9,620, previous close 9,600
- Volume
- 7×10K shares
- 650.01 million KRW 0.42× the 20-session average
Market close of 10/20 (Tue)
Where it sits in the 1-year range
3%1-year close range 8,950 to 32,000 won, 3% up from the low
3% of the way up from the lowest close in 1 year (252 sessions) · -69.9% from the high
Something to check
1 to check: operating loss
Free · no sign-inSource from 2021-05-17
Points to check
- Earningsto check-10.6B KRWOperating income over the last four quarters -10.6B KRW (loss)
- Recent filingsnot verifiedOutside filing data coverage, so not verified
- Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified
The other 3 are within the usual range
- Daily move+0.21%usual range
- Trading value0.4×usual range
- Data date10/20 (Tue)Market close
See the full check report
Quarterly results · Q1 2026
- Revenue381.61 million KRW
- vs. year ago
- +20.6%
- vs. prior quarter
- -53.8%
- Operating income-3.0B KRW
- vs. year ago
- Still a loss
- vs. prior quarter
- Still a loss
- Operating margin-793.9%
- vs. year ago
- +384.0 pp
- vs. prior quarter
- -476.5 pp
Quarterly operating income trend
As of the latest official close · 2026-10-20Valuation filing date · 2026-05-15Same sector · 바이오 R&D
Down -2.19%· 16 of 64 stocks up, preferred shares excluded · trading value 190.5B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 알테오젠 | Close over the last 20 sessions -9.6% | Down -3.35% | 51.1B KRW |
| 올릭스 | Close over the last 20 sessions -12.2% | Down -4.03% | 19.1B KRW |
| 디앤디파마텍 | Close over the last 20 sessions -11.8% | Down -1.93% | 15.1B KRW |
| 리가켐바이오 | Close over the last 20 sessions -15.4% | Down -1.41% | 12.1B KRW |
| 프로티나 | Close over the last 20 sessions +31.8% | Up +7.38% | 10.0B KRW |
Schedule
- Next data 10/22 (Thu) after 08:50
Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 81% of trading value, about 92% of market capitalisation. Coverage status →
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.